AFP-L3, a fucosylated variant of AFP, is thought to be more specific than AFP [40], and its percentage over total AFP and absolute value might be used as a biomarker for the diagnosis and recurrence of HCC after LT [38,41]. Here, AFP is linked to hepatocellular carcinoma.